The Effect of Body Mass Index on Migraine Severity in Female Patients


  • Mohammed Khalid Fakher ( MBChB, FICMS Neurology )
  • Zaki Noah Hassan ( MBChB, FICMS & Consultant i n Neurology )


Background: Both Migraine & nutritional disorders are common disorders with significant health &
socioeconomic impacts. We aimed to determine the relationshipbetween BMI and migraine headache
severity, frequency, and disability.
Methods: We collected 100 females migraineurs attending the out patient clinic of a tertiary
neurology hospital. The patients were divided into four categories, based on BMI: underweight (<18.5),
normal weight (18.5 to 24.9), overweight (25 to 29.9), andobese (>30). The headache frequency,
severity, duration and disability using MIDAS score were assessed. Multivariate analyses were
Results: On multivariate analysis, overweight patients represented 62.82% of longer headache (>24
hr) group while they represented only 22.73% among shorter headache (<24 hr) group (OR= 8.09,
95%CI=2.15-30.51, p=0.002). BMI have lost their association in multivariate analysis. Multi-parity of
2-3 and ≥4 were more common in severe headache cases than mild/moderate cases (OR=9.89, 95%CI=
1.4-69.67, p=0.021and OR=11.37, 95%CI=1.36-95.1, p= 0.025 respectively). 70.73% of patients with
severe headache were overweight compared with 42.37% of patients with mild/moderateheadache
(OR= 4.32, 95%CI=1.34-13.96, p=0.014). About 60% of patients with high MIDAS grade had ≥4 parity
compared with 17.86% of patients with low grade who had such parity (OR=7.78, 95%CI=1.27-47.61,
p=0.026). The frequency of overweight and obese patients among high grade group was 68.18% and
18.18%, respectively comparedwith 42.86% and 5.36%, respectively among low grade group with
significant differences (OR= 3.56, 95%CI=1.15-11.03, p= 0.027 and OR=7.22, 95%CI=1.1-47.14,
p=0.039, respectively).
Conclusion: BMI does have significant effects on migraine headache severity and the resulting
disability but its effects on headache frequency and duration was not supported


Headache Classification Committee of the International Headache Society (IHS)The International

Classification of Headache Disorders, 3rd edition. Cephalalgia.2018 Jan;38(1):1-211.

Nature research website. [].Visited on 18/1/2021

WHO Obesity and overweight. [ sheets/detail/obesity-andoverweight]. Visited at 1/2/2021

World Health Organization. (Health topics: A healthy lifestyle: Body mass index- BMI.

[ healthy-lifestyle/body-mass-indexbmi]

Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset andremission of chronic

daily headache in a population-based study. Pain. 2003;106(1-2):81-89.

Chorazka K, Janoska M, Domitrz I. Body mass index and its impact on migraine prevalence and severity

in female patients:preliminary results. Neurol Neurochir Pol. 2014;48(3):163-6.

Yu S, Liu R, Yang X. Body mass index and migraine: a survey of the Chineseadult population. J

Headache Pain. 2012;13(7):531-6.

Lipton RB, Stewart WF. The epidemiology of migraine. Eur Neurol. 1994;34Suppl 2:6-11.

GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, et al,. Health Effects of

Overweight and Obesity in 195 Countries over 25 Years. NEngl J Med. 2017 Jul 6;377(1):13-27. Epub 2017 Jun

Pengpid S. and Peltzer K. Overweight and obesity among adults in Iraq: Prevalence and correlates from

a national survey in 2015. Preprints ( | NOT PEER-REVIEWED | Posted: 18 November

Akerman S, Holland P, Goadsby PJ. Diencephalic and brainstem mechanisms inmigraine. Nature Rev

Neurosci 12: 570–584, 2011.

Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications

to migraine pathophysiology. J Clin Neurol 8: 89–99, 2012.

Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable orhyperresponsive in migraine?

Cephalalgia 27: 1427–1439, 2007.

Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AM.Migraine pathophysiology:

lessons from mouse models and human genetics. Lancet Neurol 14: 65–80, 2015.

Tolner EA, Houben T, Terwindt GM, de Vries B, Ferrari MD, van den Maagdenberg AM. From

migraine genes to mechanisms. Pain 156 Suppl 1: S64-74, 2015.

Niebur E, Hsiao SS, Johnson KO. Synchrony: a neural mechanism for attentionalselection? Curr Opin

Neurobiol 12: 190–194, 2002.

Karsan N, Bose P, Goadsby PJ. The Migraine Premonitory Phase. Continuum(Minneap Minn). 2018

Aug;24(4, Headache):996-1008.

Bose P, Karsan N, Goadsby PJ. The Migraine Postdrome. Continuum (MinneapMinn). 2018 Aug;24(4,


Giffin NJ, Lipton RB, Silberstein SD, et al. The migraine postdrome: An electronic diary study.

Neurology. 2016 Jul 19;87(3):309-13. Epub 2016 Jun 22.

Quintela E, Castillo J, Muñoz P, Pascual J. Premonitory and resolution symptomsin migraine: a

prospective study in 100 unselected patients. Cephalalgia 2006; 26(9):1051–1060.

Becker WJ. Acute Migraine Treatment in Adults. Headache. 2015 Jun;55(6):778- 93. Epub 2015 Apr 15.

Iljazi A, Chua A, Rich-Fiondella R, et al. Unrecognized challenges of treating status migrainosus: An

observational study. Cephalalgia. 2020 Jul;40(8):818-827

Khazaei M, Hosseini Nejad Mir N, Yadranji Aghdam F, Taheri M, Ghafouri-Fard

S. Effectiveness of intravenous dexamethasone, metoclopramide, ketorolac, andchlorpromazine for pain relief

and prevention of recurrence in the migraine headache: a prospective double-blind randomized clinical trial.

Neurol Sci. 2019May;40(5):1029-1033.

Silberstein SD, Holland S, Freitag F; Quality Standards Subcommittee of the American Academy of

Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for

episodic migraine preventionin adults: report of the Quality Standards Subcommittee of the American Academy

of Neurology and the American Headache Society. Neurology. 2012 Apr 24;78(17):1337-45. Erratum in:

Neurology. 2013 Feb 26;80(9):871.

Pringsheim T, Davenport W, Mackie; Canadian Headache Society Prophylactic Guidelines

Development Group. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012

Mar;39(2 Suppl 2):S1-59.

Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia. 2002Sep;22(7):491-512.

Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Continuum

(Minneap Minn) 2012; 18:796.

Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using

relaxation and topiramate as controls. Cephalalgia 2011;31:1428.

Ahn AH. Why does increased exercise decrease migraine? Curr Pain HeadacheRep 2013; 17:379.

Holroyd KA, Cottrell CK, O'Donnell FJ, et al. Effect of preventive (beta blocker)treatment, behavioural

migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine:

randomised controlled trial.BMJ 2010; 341:c4871.

Martin PR. Behavioral management of migraine headache triggers: learning tocope with triggers. Curr

Pain Headache Rep 2010; 14:221.

Horev A, Wirguin I, Lantsberg L, Ifergane G. A high incidence of migraine withaura among morbidly

obese women. Headache. 2005 Jul-Aug;45(7):936-8.

Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology.


Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but notchronic tension-type

headache. Neurology. 2006;67(2):252-257.

M. E. Bigal, A. Tsang, E. Loder, D. Serrano, M. L. Reed, and R. B. Lipton, “Bodymass index and episodic

headaches: A Population-Based Study,” Archives of Internal Medicine, vol. 167, no. 18, pp. 1964–1970, 2007.

B. L. Peterlin, A. L. Rosso, A. M. Rapoport, and A. I. Scher, “Obesity and migraine: the effect of age, gender

and adipose tissue distribution,” Headache,vol. 50, no. 1, pp. 52–62, 2010.

Giraud, P, and S Chauvet. “Migraine and obesity, is there a link?.” Revueneurologique vol. 169,5 (2013):


Recober, A., & Peterlin, B. L. (2014). Migraine and obesity: moving beyond BMI.Future Neurology,

(1), 37–40.

Ravid S. Migraine & paediatric obesity: a plausible link?. Indian J Med Res2014;139:343-8

Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL. Obesity and headache:part I--a systematic

review of the epidemiology of obesity and

headache. Headache. 2014;54(2):219-234.

Oakley CB, Scher AI, Recober A, Peterlin BL. Headache and obesity in thepediatric population. Curr

Pain Headache Rep. 2014;18(5):416.

Laino D, Vitaliti G, Parisi P, et al. Headache, migraine and obesity: an overviewon plausible links. J

Biol Regul Homeost Agents. 2016;30(2):333-8.

Farello G, Ferrara P, Antenucci A, Basti C, Verrotti A. The link between obesityand migraine in

childhood: a systematic review. Ital J Pediatr. 2017;43(1):27. Published 2017 Mar 7.

Pavlovic JM, Vieira JR, Lipton RB, Bond DS. Association Between Obesity andMigraine in Women.

Curr Pain Headache Rep. 2017;21(10):41. Published 2017 Aug 25.

Darabaneanu S, Overath CH, Rubin D, et al. Aerobic exercise as a therapy optionfor migraine: a pilot

study. Int J Sports Med. 2011;32(6):455-460.

Verrotti A, Di Fonzo A, Penta L, Agostinelli S, Parisi P. Obesity and headache/migraine: the importance

of weight reduction through lifestylemodifications. Biomed Res Int. 2014;2014:420858.

Cervoni, Cynthia et al. “Behavioral Weight Loss Treatments for Individuals withMigraine and Obesity.”

Current pain and headache reports vol. 20,2 (2016): 13.

Ornello R, Ripa P, Pistoia F, et al. Migraine and body mass index categories: asystematic review and

meta-analysis of observational studies. J Headache Pain.2015;16:27.

Wang J, Liu RZ, Dong Z, Yu SY. A meta-analysis of the correlation betweenobesity and migraine. Nan

Fang Yi Ke Da Xue Xue Bao. 2016;36(3):437-42.

Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine

Disability Assessment (MIDAS) score in comparison to a diary- based measure in a population sample of

migraine sufferers. Pain. 2000;88(1):41-52.

Ashkenazi, Avi, and Stephen D Silberstein. “Hormone-related headache: pathophysiology and

treatment.” CNS drugs vol. 20,2 (2006): 125-41.

World Health Organization. ()1122hio rsWipi -tsiaW mirmecnuruimu sic tsiaW . report of a WHO expert

consultation, Geneva, 8-11 December 2008. World Health Organization.


Kristoffersen ES, Børte S, Hagen K, Zwart JA, Winsvold BS. Migraine, obesityand body fat distribution

- a population-based study. J Headache Pain. 2020;21(1):97. Published 2020 Aug 6.

Huang Q, Liang X, Wang S, Mu X. Association between Body Mass Index andMigraine: A Survey of

Adult Population in China. Behav Neurol. 2018;2018:6585734. Published 2018 Apr 19.

Winter AC, Berger K, Buring JE, Kurth T. Body mass index, migraine, migrainefrequency and migraine

features in women. Cephalalgia. 2009 Feb;29(2):269-78.

Ford ES, Li C, Pearson WS, Zhao G, Strine TW, Mokdad AH. Body mass indexand headaches: findings

from a national sample of US adults. Cephalalgia. 2008;28(12):1270-1276.

Tiu DN, Das D. Assessment of relation of migraine & obesity in study population.

J Adv Med Dent Scie Res 2019; 7(2):84-86.

Mattsson, P. “Migraine headache and obesity in women aged 40-74 years: a population-based study.”

Cephalalgia: an international journal of headache vol.27,8 (2007): 877-80.

Ojha P, Malhotra V, Pandey N. Association between generalized obesity and migraine features in Indian

females. Indian J Physiol Pharmacol. 2018; 62(4):453-7.

Z. Bic, G. G. Blix, H. P. Hopp, and F. M. Leslie, “In search of the ideal treatmentfor migraine headache,”

Medical Hypotheses, vol. 50, no. 1, pp. 1–7, 1998.

C. Power, S. K. Miller, and P. T. Alpert, “Promising new causal explanations forobesity and obesityrelated diseases,” Biological Research for Nursing, vol. 8, no.3, pp. 223–233, 2007.

P. Martelletti, G. Stirparo, and M. Giacovazzo, “Proinflammatory cytokines in cervicogenic headache,”

Functional Neurology, vol. 14, no. 3, pp. 159–162, 1999.

X. Liang, S. Wang, G. Qin et al., “Tyrosine phosphorylation of NR2B contributesto chronic migraines

via increased expression of CGRP in rats,” BioMed ResearchInternational, vol. 2017, Article ID 7203458, 8

pages, 2017.]). On the other hand, migraine attacks are proposed to be contributed by inflammation.

Peterlin BL, Sacco S, Bernecker C, Scher AI (2016) Adipokines and migraine: asystematic review.

Headache. 56(4):622–644,

Kutlu S, Canpolat S, Sandal S, Ozcan M, Sarsilmaz M, Kelestimur H (2003) Effects of central and

peripheral administration of leptin on pain threshold in ratsand mice. Neuro Endocrinol Lett 24(3–4):193–196

Van Harmelen V, Reynisdottir S, Eriksson P, Thörne A, Hoffstedt J, Lönnqvist Fet al (1998) Leptin

secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 47(6):913–917

Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A et al (2009) Subcutaneous rather

than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin

Endocrinol Metab94(10):4010–4015

Dominguez C, Vieites-Prado A, Perez-Mato M, et al (2018) Role of adipocytokines in the

pathophysiology of migraine: a cross-sectional study.Cephalalgia. 38(5):904–911

Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role inmigraine? Nat Rev

Neurol 15(8):483–490

T. Kurth, J. M. Gaziano, N. R. Cook, G. Logroscino, H. C. Diener, and J. E. Buring, “Migraine and risk

of cardiovascular disease in women,” JAMA, vol. 296,no. 3, pp. 283–291, 2006.

A. Recober and B. Lee Peterlin, “Migraine and obesity: moving beyond BMI,”Future Neurology, vol. 9, no.

, pp. 37–40, 2014

V. Mohamed-Ali, J. H. Pinkney, and S. W. Coppack, “Adipose tissue as an endocrine and paracrine organ,”

International Journal of Obesity and RelatedMetabolic Disorders, vol. 22, no. 12, pp. 1145–1158, 1998

A. Sachdev and M. J. Marmura, “Metabolic syndrome and migraine,” Frontiersin Neurology, vol. 3, p.

, 2012.

W. B. Young and T. D. Rozen, “Preventive treatment of migraine: effect onweight,